Home
Choose language  
Pharmacoreport Pharmacoreport
www.pharmacoreport .com is a news site providing information about the top international pharmaceutical companies. This website will also provide other information about these pharmaceuticals like their address and locations, corporate history, clinical trials, annual report, employees, careers and jobs, health care products, research, sales, shares, dividend & stock price, and patients’ assistance program.
 
Schering   Schering

 


Founded by Ernst Schering in the year 1851 with headquarters situated at Berlin-Wedding, Germany and incorporated during 1871, Schering AG was the research-oriented pharmaceutical company that later amalgamated with Bayer during December 2006, the company then was renamed as Bayer Schering Pharma AG. The company has over 26,000 employees working in around 140 subsidiaries across the world. As per the available statistics, the company’s gross revenue was around 5 billion in the year 2003.   

 

Schering AG mainly concentrated on the business segments covering gynecology, andrology and oncology. The most known brands of Schering are perhaps from the segment of combined oral contraceptive pills. The company was also engaged in some specialized therapeutics, diagnostic devices and nuclear medications. The biggest of its German manufacturing plant is situated at Bergkamen in Germany. Schering was using the brand named Berlex Laboratories in the United States. 

 

Recently on 17th of February this year, 2007, the company has publicly made the declaration that nearly 1,000 jobs would be cut through voluntary retirement from its operations at Berlin plant with immediate effect until March 2008.

 

The major popular product line of Schering include various sectors such as: Gynecology & Andrology division offering contraceptives, menopause management, gynecological therapy and andrology; Diagnostic Imaging like X-ray contrast media, contrast media for Magnetic Resonance Imaging-MRI, application technologies for contrast media; Specialized therapeutics like Central Nervous System-CNS and Oncology like Hematology and Solid Tumors.

 

The recognized brands of Bayer Schering Pharma AG include: Betaferon, Betaseron, Yasmin, YAZ, Yasminelle, Kogenate, Adalat, Cipro, Ciprobay, Avalox, Avelox, Magnevist, Levitra, Glucobay and Mirena.


, AstraZeneka , Chugei Pharmaceutical Co , Baayer , Chiren Corporation , Dr Redys Laboratories Ltd , Sumitemo Chemical Co , Whyeth , Abott Laboratories , Merk and Co
Latest News About schering-plough
WALL STREET OUTLOOK - higher as AMD, HCA deals excite; Schering-Plough...
Schering-plow company used the quarter salaries of second of 237 mln or reported 16 cents per share, on revenue on 11 pct years-on-year to 2.8 bln used. .....More
Schering-Plough Licenses Worldwide Rights to Pradefovir, Oral...
,) For excluding worldwide development and commercial rights to Pradefovir, an investigational oral antiviral composition momentarily in Phasenii clinically.....More
Schering-Plough& Cuts Highlight Turnaround Potential
Morgan Stanley said that Schering-Ploughand decision to restrict, in Puerto Rico and New Jersey, are a positive sign that the companyand gross margins will improve, .....More
Introducing the New Schering-Plough
Sincerity short you? You betting to Gunsten row and even transportation? Then stay away of freed Hassan and the new Schering-Pflügt (SGP - commentary - Cramerand....More
Schering-Plough To Sell New Drug
The Schering-Pfluggesellschaft said today that it had paid Centocor Inc. $20 million for the rights, Avakine to selling, a drug for Crohnand illness, .....More
At Schering-Plough, the Pain Only Grows
The sick drug manufacturer is believes may be now the goal of a police ascertainment the Wall Street analyst andquot; very good wider, .....More
Schering-Plough& Blowout
Schering-plow (NYSE: SGP) -third quarter has is come in reported impressively the revenue of numbers at $1.99 billions, salary at $432 million, resulting in profit margins.....More
Schering-Plough& Net Earnings Were Flat in the Second Quarter
Through Reuters the Schering-Pfluggesellschaft said yesterday that its second quarter were changed salaries small by a year earlier, than. here place....More
Positive on Schering-Plough
Schering-plow (SGP searches: NYSE - commentary - - Cramerand) comparatively approve on a price-to-revenue basis takes regards and sees further good results in its.....More
TEXT-Moody& may cut Schering-Plough& lt ratings
Moodyand COMPANY PLACES LONG-TERM estimations OF Schering-PLOW (A3 SR. ... Schering-PLOW reported, that it negative operation cash flow. erzeugt...More